| | |
| Bed rest after IVF doesn't help Friday, Jun 28, 2013 12:21 PM PDT By Kerry Grens NEW YORK (Reuters Health) - Bed rest immediately after an in vitro fertilization (IVF) procedure, despite being common practice, did not help women ultimately have a baby in a new study. "The old wives' tale of bed rest should be debunked once and for all, that you don't need bed rest in any way, shape or form," said Dr. Jani Jensen, a fertility expert at the Mayo Clinic, who was not part of the study. ... Full Story | Top |
| Hormone therapy, calcium may lower fracture risk Friday, Jun 28, 2013 11:30 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - Women taking a combination of hormone therapy and calcium and vitamin D tablets after menopause were less likely to fracture their hip than those not taking hormones or supplements, in a new study. "We always tell women to take calcium and vitamin D," said Dr. Michele Curtis, a women's health researcher from the University of Texas Health Science Center at Houston. "At the end of the day what this study really says is, what you thought was a good thing to do really is a good thing to do. ... Full Story | Top |
| New labels tied to fewer child poisonings by OTC meds Friday, Jun 28, 2013 10:19 AM PDT By Kathryn Doyle NEW YORK (Reuters Health) - Fewer small children have been sickened or died from accidentally taking cough and cold medicines meant only for older ages, according to a new study of the effects of recent label changes on these over the counter products. High doses of antihistamines can cause coma, seizure and abnormal heart rhythms in kids, and an overdose of the pain reliever acetaminophen can cause liver failure, according to the study's lead author Dr. Maryann Mazer-Amirshahi of the department of emergency medicine at The George Washington University in Washington, D.C. ... Full Story | Top |
| Obama pledges to help Africa, pays tribute to Mandela Friday, Jun 28, 2013 10:03 AM PDT  By Mark Felsenthal and Jeff Mason ABOARD AIR FORCE ONE (Reuters) - U.S. President Barack Obama paid tribute to anti-apartheid hero Nelson Mandela as he flew to South Africa on Friday but played down expectations of a meeting with the ailing black leader during an Africa tour promoting democracy and food security. White House officials hope Obama's three-nation tour of Africa - his first substantial visit to the continent since taking office in 2009 - will compensate for what some view as years of neglect by America's first black president. ... Full Story | Top |
| Pennsylvania hospitals' ban on hiring smokers prompts debate Friday, Jun 28, 2013 09:52 AM PDT By Dave Warner PHILADELPHIA (Reuters) - With just days to go before two of the city's most prestigious hospitals refuse to hire smokers, the ban has relit a debate about the wisdom of regulating workers' behavior away from the workplace. Both the highly rated University of Pennsylvania Health System, which includes the Hospital of the University of Pennsylvania, as well as the Children's Hospital of Philadelphia, named by US News and World Report as America's top children's hospital this year, will join dozens of hospitals across the country when they implement their policy on Monday, July 1. ... Full Story | Top |
| Obama administration sets final contraceptives rule for faith-affiliated employers Friday, Jun 28, 2013 08:54 AM PDT WASHINGTON (Reuters) - The Obama administration on Friday issued its final rule requiring health insurance coverage of contraceptives for the employees of religiously affiliated universities, hospitals and other institutions, just as the new policy faces mounting legal challenges. Officials said the rule does not differ substantially from a proposed version released earlier this year that sought to insulate employers who oppose birth control on religious grounds. ... Full Story | Top |
| Dutch drugmaker Prosensa jumps 54 percent in U.S. stock market debut Friday, Jun 28, 2013 08:50 AM PDT (Reuters) - Dutch drugmaker Prosensa Holding received a buoyant welcome in its market debut on the Nasdaq, a day after U.S. health regulators granted a "breakthrough status" to its drug to treat a rare disease. Prosensa's shares opened $7 above its initial public offering price of $13 and were up 46 percent at $19.05 about an hour after they started trading. Prosensa developed drisapersen in partnership with GlaxoSmithKline Plc to treat Duchenne Muscular Dystrophy (DMD), a muscle-wasting disorder that affects one in every 3,500 newborn boys and has no available cure. ... Full Story | Top |
| Roche's subcutaneous Herceptin gets EU green light Friday, Jun 28, 2013 08:49 AM PDT ZURICH (Reuters) - Swiss drugmaker Roche said on Friday that European regulators had given a green light to a new formulation of its breast cancer drug Herceptin, which it hopes will help extend the medicine's shelf life. The European Medicines Agency (EMA) said that its experts had recommended approval of a new injectable version of Herceptin, which cuts down treatment time to just two to five minutes. It currently takes between 30 to 90 minutes to administer the drug intravenously. ... Full Story | Top |
| Regulators pave way for biosimilar drug breakthrough Friday, Jun 28, 2013 08:35 AM PDT LONDON/ZURICH (Reuters) - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis. The European Medicines Agency (EMA) said on Friday that its experts had backed approval of two copycat versions of Johnson & Johnson and Merck & Co's blockbuster rheumatoid arthritis drug Remicade - the first time a green light has been given for such antibody-based medicines. ... Full Story | Top |
| Regulators pave way for dissimilar drug breakthrough Friday, Jun 28, 2013 08:34 AM PDT LONDON/ZURICH (Reuters) - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis. The European Medicines Agency (EMA) said on Friday that its experts had backed approval of two copycat versions of Johnson & Johnson and Merck & Co's blockbuster rheumatoid arthritis drug Remicade - the first time a green light has been given for such antibody-based medicines. ... Full Story | Top |
| Mandela showing 'great improvement', ex-wife Winnie says Friday, Jun 28, 2013 07:39 AM PDT  JOHANNESBURG (Reuters) - Former South African President Nelson Mandela is showing a "great improvement" in his health compared to a few days ago, his ex-wife, Winnie Madikizela-Mandela, said on Friday. "I'm not a doctor but I can say that from what he was a few days ago there is great improvement," she told reporters outside Mandela's former home in the Johannesburg township of Soweto. (Writing by Ed Cropley; Editing by Pascal Fletcher) Full Story | Top |
| Sanofi's MS drugs get double boost in Europe Friday, Jun 28, 2013 06:05 AM PDT LONDON (Reuters) - Sanofi's hopes in the multiple sclerosis market received a double boost on Friday as the European regulator backed an injectable treatment and adopted a more positive stance toward a pill for the neurodegenerative disease. The European Medicines Agency said it was recommending Lemtrada, Sanofi's biggest MS drug hope, for relapsing-remitting MS, ending a quarter-century development saga for the injectable treatment. ... Full Story | Top |
| Raptor's rare disease drug recommended in Europe Friday, Jun 28, 2013 04:41 AM PDT LONDON (Reuters) - European regulators have recommended approval of a drug from Raptor Pharmaceutical to treat a rare genetic disorder that can cause irreversible tissue damage, organ failure and premature death. Friday's green light for Procysbi from the European Medicines Agency (EMA) follows U.S. approval of the drug in April. The medicine is designed to treat nephropathic cystinosis, the most common form of a disease known as cystinosis, in which toxic levels of cystine, a naturally occurring amino acid, build up in the body's cells and organs. ... Full Story | Top |
| Missing nuclear material may pose attack threat: IAEA Friday, Jun 28, 2013 02:47 AM PDT By Fredrik Dahl VIENNA (Reuters) - Nuclear and radioactive materials are still going missing and the information the United Nations atomic agency receives about such incidents may be the tip of the iceberg, said a senior U.N. official. Any loss or theft of highly enriched uranium, plutonium or different types of radioactive sources is potentially serious as al Qaeda-style militants could try to use them to make a crude nuclear device or a so-called dirty bomb, experts say. Khammar Mrabit, a director of the U.N. ... Full Story | Top |
| Britain plans world's first go-ahead for '3-parent' IVF babies Thursday, Jun 27, 2013 11:34 PM PDT By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - Britain is planning to become the first country in the world to offer controversial "three-parent" fertility treatments to families who want to avoid passing on incurable diseases to their children. The methods, currently only at the research stage in laboratories in Britain and the United States, would for the first time involve implanting genetically modified embryos into women. Critics said the technique was ethically suspect and would eventually lead to a eugenic 'designer baby' market. ... Full Story | Top |
|
No comments:
Post a Comment